巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Addex Therapeutics Ltd

    ADXN
    3.600
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Addex Therapeutics Ltd - 延遲價格・最後更新於 27/05 4:19
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    3.600
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    2.560
    賣出
    4.760
    每手股數
    --
    市值(百萬)
    22.73
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    11.480 - 3.050
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Addex Therapeutics Ltd
    證券代碼
    ADXN.US
    所屬板塊
    Biotechnology
    公司業務
    Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
    發行量
    6316358
    公司總部
    Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68
    公司網址
    http://www.addextherapeutics.com
    公司電郵
    chris.maggos@addexpharma.com
    公司電話
    +41 228841555
    暫無內容

    關於

    Addex Therapeutics Ltd(ADXN.US)所屬的行業板塊為Biotechnology。
    Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
    詳細公司背景可參考: http://www.addextherapeutics.com